Susceptibility of clinical bacterial isolates to ciprofloxacin in the united states
- 1 March 1994
- journal article
- research article
- Published by Springer Nature in Infection
- Vol. 22 (2), S80-S89
- https://doi.org/10.1007/bf01793571
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Rapid Development of Ciprofloxacin Resistance in Methicillin-Susceptible and -Resistant Staphylococcus aureusThe Journal of Infectious Diseases, 1991
- Mode of action of the new quinolones: New dataEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospitalAntimicrobial Agents and Chemotherapy, 1990
- Emergence of Ciprofloxacin Resistance in Nosocomial Methicillin-Resistant Staphylococcus aureus IsolatesArchives of Internal Medicine, 1990
- Increasing resistance of Staphylococcus aureus to ciprofloxacinAntimicrobial Agents and Chemotherapy, 1990
- Persistence of Pseudomonas aeruginosa during ciprofloxacin therapy of a cystic fibrosis patient: transient resistance to quinolones and protein F-deficiencyJournal of Antimicrobial Chemotherapy, 1990
- Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus:clinical significance and therapeutic approachesJournal of Antimicrobial Chemotherapy, 1990
- Bacterial Resistance to Quinolones: Mechanisms and Clinical ImportanceClinical Infectious Diseases, 1989
- Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacinAntimicrobial Agents and Chemotherapy, 1988
- Bacterial Resistance to FluoroquinolonesClinical Infectious Diseases, 1988